<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39418288</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 variant survey: Comparison of RT-PCR screening with TGS and variant distribution across two divisions of Bangladesh.</ArticleTitle><Pagination><StartPage>e0311993</StartPage><MedlinePgn>e0311993</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311993</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311993</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The widespread increase in multiple variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since 2020 is causing significant health concerns worldwide. While whole-genome sequencing (WGS) has played a leading role in surveillance programs, many local laboratories lack the expertise and resources. Thus, we aimed to investigate the circulating SARS-CoV-2 variants and evaluate the performance of multiplexed real-time reverse transcription-PCR (RT-PCR) for screening and monitoring the emergence of new SARS-CoV-2 variants in Bangladesh.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 600 confirmed SARS-CoV-2-positive cases were enrolled either prospectively or retrospectively from two divisions of Bangladesh. The samples were screened by variant RT-PCR targeting five mutations of the spike gene (N501Y, P681R, L452R, E484K, E484Q). A subsample of the study population was also selected for third-generation sequencing (TGS) and the results were compared to the variant RT-PCR screening. An in-depth comparison was made between the two methods in terms of congruence and cost-benefit.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Seven variants were detected among samples, with similar distributions of the variants across both divisions. Variant RT-PCR for the targeted mutations lead to a 98.5% call rate; only nine samples failed to be determined. No association was found regarding the demographic features, clinical criteria, or routine RT-PCR Ct values across the variants. The clade diversity of the sequenced subpopulation (n = 99) exhibited similar distributions across the two study sites and other epidemiologic variables. Variant RT-PCR successfully distinguished variants of concern (VOCs) and variants of interest (VOIs); however, 8% discrepancy was observed for the closest lineages. Moreover, the variant RT-PCR represented an ideal balance of cost, time, and accuracy that outweigh their limitations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on the strong agreement of variant RT-PCR with TGS, such rapid, easily accessible approaches of rapid strain typing are essential in the context of pandemic responses to guide both treatment decisions and public health measures.</AbstractText><CopyrightInformation>Copyright: © 2024 Kawser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kawser</LastName><ForeName>Zannat</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7628-137X</Identifier><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Saikt</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0000-2432-5588</Identifier><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westeel</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondation Mérieux, Direction Médicale et Scientifique, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habib</LastName><ForeName>Mohammad Tanbir</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Mohabbat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetic Engineering and Biotechnology, University of Chittagong, Chittagong, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulbul</LastName><ForeName>Md Rakibul Hassan</ForeName><Initials>MRH</Initials><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bangladesh Institute of Tropical and Infectious Disease (BITID), Fouzderhat, Chittagong, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukta</LastName><ForeName>Sharmin Aktar</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0009-0006-8608-8753</Identifier><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Md Zahirul</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bangladesh Institute of Tropical and Infectious Disease (BITID), Fouzderhat, Chittagong, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Md Zakir</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Bangladesh Institute of Tropical and Infectious Disease (BITID), Fouzderhat, Chittagong, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afrad</LastName><ForeName>Mokibul Hassan</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Manjur Hossain</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirin</LastName><ForeName>Tahmina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, Disease Control, and Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Md Shakeel</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-3405-2146</Identifier><AffiliationInfo><Affiliation>Bangladesh Institute of Tropical and Infectious Disease (BITID), Fouzderhat, Chittagong, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berland</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-6337-3715</Identifier><AffiliationInfo><Affiliation>Fondation Mérieux, Direction Médicale et Scientifique, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komurian-Pradel</LastName><ForeName>Florence</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1023-0796</Identifier><AffiliationInfo><Affiliation>Fondation Mérieux, Direction Médicale et Scientifique, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadri</LastName><ForeName>Firdausi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39418288</ArticleId><ArticleId IdType="pmc">PMC11486398</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311993</ArticleId><ArticleId IdType="pii">PONE-D-24-15584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramesh S, Govindarajulu M, Parise RS, Neel L, Shankar T, Patel S, et al.. Emerging SARS CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy. Vaccines (Basel). 2021. Oct 18;9(10):1195. doi: 10.3390/vaccines9101195 ; PMCID: PMC8537675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101195</ArticleId><ArticleId IdType="pmc">PMC8537675</ArticleId><ArticleId IdType="pubmed">34696303</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin SZ, Islam MT, Paul SK, Kobayashi N, Parvin R. Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021. Virology. 2022. Jan 2;565:29–37. doi: 10.1016/j.virol.2021.10.005 Epub 2021 Oct 22. ; PMCID: PMC8531988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC8531988</ArticleId><ArticleId IdType="pubmed">34700068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari C, Benusic M, Prystajecky N, Sbihi H, Kamelian K, Hoang L. Epidemiological analysis of the emergence and disappearance of the SARS-CoV-2 Kappa variant within a region of British Columbia, Canada. Can Commun Dis Rep. 2022. Jan 26;48(1):22–26. doi: 10.14745/ccdr.v48i01a04 ; PMCID: PMC8856721.</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v48i01a04</ArticleId><ArticleId IdType="pmc">PMC8856721</ArticleId><ArticleId IdType="pubmed">35273466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med Microbiol Immunol. 2022. Jun;211(2–3):79–103. doi: 10.1007/s00430-022-00729-6 Epub 2022 Mar 2. ; PMCID: PMC8889515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00729-6</ArticleId><ArticleId IdType="pmc">PMC8889515</ArticleId><ArticleId IdType="pubmed">35235048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayeed MA, Ferdous J, Saha O, Islam S, Choudhury SD, Abedin J, et al.. Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh. Trop Med Infect Dis. 2022. Aug 20;7(8):197. doi: 10.3390/tropicalmed7080197 ; PMCID: PMC9414541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7080197</ArticleId><ArticleId IdType="pmc">PMC9414541</ArticleId><ArticleId IdType="pubmed">36006289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Jean S, Eltringham R, Madison J, Snyder P, Tu H, et al.. Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation. J Clin Microbiol. 2021. Jul 19;59(8):e0092621. doi: 10.1128/JCM.00926-21 Epub 2021 Jul 19. ; PMCID: PMC8288299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00926-21</ArticleId><ArticleId IdType="pmc">PMC8288299</ArticleId><ArticleId IdType="pubmed">34011523</ArticleId></ArticleIdList></Reference><Reference><Citation>Camp JV, Buchta C, Jovanovic J, Puchhammer-Stöckl E, Benka B, Griesmacher A, et al.. RT-PCR based SARS-CoV-2 variant screening assays require careful quality control. J Clin Virol. 2021 Aug;141:104905. doi: 10.1016/j.jcv.2021.104905 Epub 2021 Jul 7. ; PMCID: PMC8262392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104905</ArticleId><ArticleId IdType="pmc">PMC8262392</ArticleId><ArticleId IdType="pubmed">34273859</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian S, Potdar V, Jadhav S, Yadav P, Gupta N, Das M, et al.. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms. 2021. Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542 ; PMCID: PMC8307577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071542</ArticleId><ArticleId IdType="pmc">PMC8307577</ArticleId><ArticleId IdType="pubmed">34361977</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu JYL, Chong YM, Sam IC, Chan YF. SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021. J Virol Methods. 2022. Mar;301:114462. doi: 10.1016/j.jviromet.2022.114462 Epub 2022 Jan 10. Erratum in: J Virol Methods. 2022 Nov;309:114596. ; PMCID: PMC8744358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2022.114462</ArticleId><ArticleId IdType="pmc">PMC8744358</ArticleId><ArticleId IdType="pubmed">35026305</ArticleId></ArticleIdList></Reference><Reference><Citation>Muñoz-Gallego I, Meléndez Carmona MÁ, Martín Higuera C, Viedma E, Delgado R, Folgueira MD. Rapid screening of SARS-CoV-2 variants, a key tool for pandemic surveillance. Sci Rep. 2023. Jul 8;13(1):11094. doi: 10.1038/s41598-023-37866-8 ; PMCID: PMC10329708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-37866-8</ArticleId><ArticleId IdType="pmc">PMC10329708</ArticleId><ArticleId IdType="pubmed">37422474</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, et al.. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature. 2022. Feb;602(7896):294–299. doi: 10.1038/s41586-021-04245-0 Epub 2021 Nov 24. ; PMCID: PMC8900207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04245-0</ArticleId><ArticleId IdType="pmc">PMC8900207</ArticleId><ArticleId IdType="pubmed">34818667</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J, Malhotra AG, Biswas D, Shankar P, Lokhande L, Yadav AK, et al.. Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India. Genes (Basel). 2021. Nov 16;12(11):1803. doi: 10.3390/genes12111803 ; PMCID: PMC8620562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12111803</ArticleId><ArticleId IdType="pmc">PMC8620562</ArticleId><ArticleId IdType="pubmed">34828410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, Sun Y, Zhou J, Ye Q. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape. Front Immunol. 2021. Nov 30;12:751778. doi: 10.3389/fimmu.2021.751778 ; PMCID: PMC8669155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.751778</ArticleId><ArticleId IdType="pmc">PMC8669155</ArticleId><ArticleId IdType="pubmed">34917076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Liu J, Johnson BA, Xia H, Ku Z, Schindewolf C, et al.. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv [Preprint]. 2021. Sep 5:2021.08.12.456173. doi: 10.1101/2021.08.12.456173 Update in: Cell Rep. 2022 May 17;39(7):110829. ; PMCID: PMC8404900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.12.456173</ArticleId><ArticleId IdType="pmc">PMC9050581</ArticleId><ArticleId IdType="pubmed">35550680</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdurme L, Danesh G, Trombert-Paolantoni S, Sofonea MT, Noel V, Foulongne V, et al.. Spread of SARS-CoV-2 Delta variant infections bearing the S:E484Q and S:T95I mutations in July and August 2021 in France. medRxiv [Preprint]. 2021: 2021.09.13.21263371. 10.1101/2021.09.13.21263371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.13.21263371</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M, Bin Manjur OH, Hasda L, Habib MT, Afrad MH, Khan MH, et al.. Genome Sequences of 23 SARS-CoV-2 Omicron-Lineage Strains from Bangladesh. Microbiol Resour Announc. 2023; 12:e00950–22. doi: 10.1128/mra.00950-22 ; PMCID: PMC9872676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mra.00950-22</ArticleId><ArticleId IdType="pmc">PMC9872676</ArticleId><ArticleId IdType="pubmed">36472422</ArticleId></ArticleIdList></Reference><Reference><Citation>Borillo GA, Kagan RM, Marlowe EM. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays. Front Cell Infect Microbiol. 2022. May 10;12:894613. doi: 10.3389/fcimb.2022.894613 ; PMCID: PMC9127862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.894613</ArticleId><ArticleId IdType="pmc">PMC9127862</ArticleId><ArticleId IdType="pubmed">35619652</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves Cabecinhas AR, Roloff T, Stange M, Bertelli C, Huber M, Ramette A, et al.. SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing. Microorganisms. 2021. Mar 25;9(4):677. doi: 10.3390/microorganisms9040677 ; PMCID: PMC8064472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9040677</ArticleId><ArticleId IdType="pmc">PMC8064472</ArticleId><ArticleId IdType="pubmed">33806013</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogels CBF, Breban MI, Ott IM, Alpert T, Petrone ME, Watkins AE, et al.. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. PLoS Biol. 2021. May 7;19(5):e3001236. doi: 10.1371/journal.pbio.3001236 ; PMCID: PMC8133773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001236</ArticleId><ArticleId IdType="pmc">PMC8133773</ArticleId><ArticleId IdType="pubmed">33961632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubair M, Begum MN, Rahman S, Haider SMA, Moon SB, Hossain ME, et al.. SARS-CoV-2 Omicron variants in Bangladesh: Pandemic to endemic. Health Sci Rep. 2023. Mar 2;6(3):e1134. doi: 10.1002/hsr2.1134 ; PMCID: PMC9981876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1134</ArticleId><ArticleId IdType="pmc">PMC9981876</ArticleId><ArticleId IdType="pubmed">36875934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikam C, Suraweera W, Fu SHH, Brown PE, Nagelkerke N, Jha P. PCR Test Positivity and Viral Loads during Three SARS-CoV-2 Viral Waves in Mumbai, India. Biomedicines. 2023. Jul 8;11(7):1939. doi: 10.3390/biomedicines11071939 ; PMCID: PMC10377402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071939</ArticleId><ArticleId IdType="pmc">PMC10377402</ArticleId><ArticleId IdType="pubmed">37509578</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M, Shirin T, Rahman S, Rahman MM, Hossain ME, Khan MH, et al.. The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh. Transbound Emerg Dis. 2021 Nov;68(6):3000–3001. doi: 10.1111/tbed.14203 Epub 2021 Jul 2. ; PMCID: PMC8447378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.14203</ArticleId><ArticleId IdType="pmc">PMC8447378</ArticleId><ArticleId IdType="pubmed">34170629</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman A, Mallah SI, Alawadhi A, Perna S, Janahi EM, AlQahtani MM. Association between RT-PCR Ct values and COVID-19 new daily cases: a multicenter cross-sectional study. Infez Med. 2021. Sep 10;29(3):416–426. doi: 10.53854/liim-2903-13 ; PMCID: PMC8805503.</Citation><ArticleIdList><ArticleId IdType="doi">10.53854/liim-2903-13</ArticleId><ArticleId IdType="pmc">PMC8805503</ArticleId><ArticleId IdType="pubmed">35146347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawser Z, Hossain M, Suliman S, Lockman S, Gitaka J, Bandawe G, et al.. An Assessment of a Rapid SARS-CoV-2 Antigen Test in Bangladesh. Am J Trop Med Hyg. 2022. Aug 15;107(4):845–849. doi: 10.4269/ajtmh.22-0068 ; PMCID: PMC9651516.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.22-0068</ArticleId><ArticleId IdType="pmc">PMC9651516</ArticleId><ArticleId IdType="pubmed">35970285</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al.. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021. Jul;19(7):409–424. doi: 10.1038/s41579-021-00573-0 Epub 2021 Jun 1. ; PMCID: PMC8167834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Song S, Fan Q, Shen S, Wang H, Zhou B, Ge X, et al.. Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies. Cell Discov. 2021. Nov 23;7(1):112. doi: 10.1038/s41421-021-00347-1 ; PMCID: PMC8608826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00347-1</ArticleId><ArticleId IdType="pmc">PMC8608826</ArticleId><ArticleId IdType="pubmed">34811350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang Z, Ma L, Zhu X, Li B, Huang Y, et al.. S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants. Vaccines (Basel). 2023. Jan 16;11(1):193. doi: 10.3390/vaccines11010193 ; PMCID: PMC9863711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11010193</ArticleId><ArticleId IdType="pmc">PMC9863711</ArticleId><ArticleId IdType="pubmed">36680037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al.. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021. Dec;22(12):757–773. doi: 10.1038/s41576-021-00408-x Epub 2021 Sep 17. ; PMCID: PMC8447121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Baj A, Novazzi F, Pasciuta R, Genoni A, Ferrante FD, Valli M, et al.. Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy. Emerg Infect Dis. 2021. Dec;27(12):3180–3182. doi: 10.3201/eid2712.211792 Epub 2021 Sep 9. ; PMCID: PMC8632179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2712.211792</ArticleId><ArticleId IdType="pmc">PMC8632179</ArticleId><ArticleId IdType="pubmed">34499599</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>